Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06546163 · ClinicalTrials.gov registry record · NA
The Effects of Heart Rate Variability Biofeedback on College Students With Disordered Eating
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT06546163: Completed NA study, sponsored by Arizona State University.
NCT06546163 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06546163, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The goal of this clinical trial study is to test the heart rate variability biofeedback training in female college students with eating disorders and compare the results between intervention and control group. The main questions it aims to answer are: * How does heart rate variability biofeedback (HRVB) training impact behaviors related to eating disorders (EDs) and the perceived stress associated with these behaviors? * What difference are observed in the quality of life and stress responses between individuals trained in HRVB protocol and those in the wait list condition? * Does HRVB training enhance heart resilience and improve the ability to cope with psychosocial stressors in young women with eating disorders, compared to those in the wait list condition? Participants will be asked to do the following steps: * Baseline heart rate variability assessment and completion of the baseline questionnaire * HRVB training session and two weeks of at-home HRVB practice-10 minutes daily, (intervention group) * Post-intervention questionnaire completion and heart rate variability assessment * Optional interview (for intervention group) and HRVB training session (for control group) Researchers will compare the results of intervention group with control group to see if the participants improve in levels of emotional health, quality of life, and resilience.
Primary Outcome
The Emwave Pro Plus device from HeartMath will be used to collect HRV data and heart rate using a 3-minutes "neutral" protocol (we call "waiting at the bus stop" implying that no particular intent for breath or mindful state is to be evoked) to understand the benefits of HRVB. In addition, HRV measures will be obtained for the 1-minute paced breathing period to understand the effects of paced breathing on HRV. The following precautions will be provided as instructions to participants prior to da
Interventions
- BEHAVIORAL Heart rate variability biofeedback
- BEHAVIORAL Educational materials
- BEHAVIORAL Baseline survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2024-01-08 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
What the finished NCT06546163 record still lists
NCT06546163 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Heart rate variability biofeedback is the first listed.
NCT06546163 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06546163 about?
NCT06546163 is a clinical study titled "The Effects of Heart Rate Variability Biofeedback on College Students With Disordered Eating". The goal of this clinical trial study is to test the heart rate variability biofeedback training in female college students with eating disorders and compare the results between intervention and control group. The main questions it aims to answer are: * How does heart rate variability biofeedback (...
What is the current status of trial NCT06546163?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2024-01-08. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT06546163?
The interventions under investigation include: Heart rate variability biofeedback (BEHAVIORAL), Educational materials (BEHAVIORAL), Baseline survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT06546163?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06546163's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI